SLC5A2 and cancer: For example, the administration of dapagliflozin, an SGLT2 inhibitor that lowers blood glucose, and a controlled-release mitochondrial protonophore (CRMP) suppresses cancer growth in mice by reversing hyperinsulinemia91.